ArticleMolecular diversity2026

Targeting p53-MDM2 pathway with novel triazole-oxazole hybrids: a fragment-based drug discovery approach for next-generation cancer therapies.

Apurva Prajapati et al.PubMed ↗Publisher ↗

No numbers read from the abstract.